Are Max Healthcare latest results good or bad?
Max Healthcare's latest results are mixed; they reported record high net sales and profitability, but rising interest expenses pose challenges in managing costs effectively. Overall, while the financial performance shows growth, concerns about sustainability remain.
Max Healthcare Institute has reported its financial results for the quarter ending March 2025, showcasing a record high in net sales of Rs 1,909.74 crore, which reflects consistent growth over the last five quarters. The operating profit for the quarter was Rs 511.62 crore, indicating a positive trend in profitability. Additionally, profit before tax (PBT) reached Rs 355.58 crore, while profit after tax (PAT) was Rs 319.00 crore, both representing the highest figures in the last five quarters. Earnings per share (EPS) stood at Rs 3.28, suggesting enhanced profitability for shareholders.However, the results also reveal challenges, particularly with interest expenses that surged to Rs 107.60 crore, marking a significant increase compared to the previous half-year. This rise in borrowing costs has led to a decline in the operating profit to interest ratio, which fell to 9.27 times, indicating a reduced capacity to manage interest payments effectively. While non-operating income reached Rs 46.92 crore, the sustainability of this income remains uncertain.
In summary, Max Healthcare's latest financial results reflect a mix of record sales and profitability alongside rising interest expenses and challenges in managing those costs. The company saw an adjustment in its evaluation based on these results.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
